15 minutes delayed
Comments
Loading...
Navidea Biopharmaceutical (NAVB) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNavidea Biopharmaceutical (OTC:NAVB) Stock Quotes, Forecast and News Summary
Navidea Biopharmaceutical Stock (OTC: NAVB) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 24.30K |
| Day Range | - - - |
| 52 Wk Range | 0.00 - 0.13 |
| Market Cap | $100.08K |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | OTC |
| RSI | 0 |
| Short Interest | - |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Navidea Biopharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its pr...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Navidea Biopharmaceutical (NAVB) stock?
You can purchase shares of Navidea Biopharmaceutical (OTCEM:NAVB) through any online brokerage.
Who are Navidea Biopharmaceutical (NAVB) competitors?
There are no as such competitors for Navidea Biopharmaceutical.
What is the forecast, or price target, for Navidea Biopharmaceutical (NAVB) stock?
There is no analysis for Navidea Biopharmaceutical to provide a consensus price target.
What is the current price for Navidea Biopharmaceutical (NAVB)?
The stock price for Navidea Biopharmaceutical (OTCEM: NAVB) is $0.001 last updated September 17, 2024 at 11:50 AM EDT.
Does Navidea Biopharmaceutical (NAVB) pay a dividend?
There are no upcoming dividends for Navidea Biopharmaceutical.
When is Navidea Biopharmaceutical (OTCEM:NAVB) reporting earnings?
Navidea Biopharmaceutical’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Navidea Biopharmaceutical (NAVB) going to split?
There is no upcoming split for Navidea Biopharmaceutical.
What sector and industry does Navidea Biopharmaceutical (NAVB) operate in?
Navidea Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.